Target intelligence / Profile preview

MicroRNA 548ah (MIR548AH)

Target
MIR548AH
Molecular classification
microRNA, non-coding RNA, regulatory RNA
01

Overview

MicroRNA 548ah (MIR548AH) is a member of the miR-548 family, classified as a small, non-coding regulatory RNA molecule (microRNA) typically 20-24 nucleotides in length. It is encoded by the human genome and commonly designated as "hsa-mir-548ah" in databases. Like other microRNAs, miR-548ah acts mainly at the post-transcriptional level to silence or degrade specific mRNA targets, thereby influencing gene expression. This particular microRNA has been shown to be significantly upregulated in peripheral blood mononuclear cells (PBMCs) during immune activation phases of chronic hepatitis B infection, where it regulates immune responses by targeting IFN-γ receptor 1 mRNA and thereby modulating cytokine signaling. MIR548AH may participate in major cellular signaling pathways, including Wnt, MAPK, and TGF-β, and is considered a potential biomarker and therapeutic target in HBV and possibly other immune-related diseases. Its broad impact on cellular processes and immune regulation means that therapeutic interventions involving MIR548AH require careful consideration of off-target and safety profiles.

Other names
hsa-mir-548ahhsa-miR-548ah-5pmiRNA-548ah
02

Mechanism of action

Binds to complementary sequences on target mRNAs (notably IFN-γ receptor 1 mRNA), inhibiting expression by mRNA degradation or translational repression Down-regulates host antiviral response

03

Biological functions

Post-transcriptional regulation of gene expressionRNA silencingModulation of immune responseRegulation of protein binding and multiple signaling pathways including Wnt, MAPK, and TGF-β
04

Disease associations

Chronic hepatitis B (CHB)InflammationPotential viral pathogenesis facilitation
05

Safety considerations

Unintended modulation of immune function due to broad regulatory effects on gene expressionPotential off-target effects leading to dysregulation of immune or antiviral responses
06

Biomarkers

Circulating miR-548ah (potential as a biomarker in chronic hepatitis B and possibly for other immune activation conditions)

Beyond the preview

Go deeper on MicroRNA 548ah (MIR548AH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 548ah (MIR548AH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call